Psych Central

FDA Alert News

Latuda Approved to Treat Schizophrenia

October 28th, 2010
Latuda Approved to Treat SchizophreniaOn Thursday, the U.S. Food and Drug Administration today approved Latuda (lurasidone HCl) -- an atypical antipsychotic medication -- for the treatment of adults with schizophrenia. Schizophrenia is characterized ...

First ADHD Add-On Drug Approved

October 7th, 2010
The U.S. Food and Drug Administration (FDA) has given the green light to the nonstimulant medication Kapvay (clonidine hydrochloride) as the first drug used to treat attention deficit hyperactivity disorder (ADHD) that can be used as an add-on therapy to stimulant medication. Kapvay ...

FDA Warns of Potential Meningitis Risk Associated with Lamictal

August 14th, 2010
A new side effect associated with the psychiatric medication Lamictal has been discovered. On August 12th the U.S. Food and Drug Administration (FDA) issued a new warning that Lamictal (lamotrigine) has a very low risk of causing a condition known as aseptic meningitis. “Aseptic meningitis is ...

Female Viagra Ineffective

June 21st, 2010
After much review and public controversy, the FDA met this week and determined that flibanserin, a new medication that was hoped to be an effective treatment for female sexual arousal disorder, did not significantly improve symptoms of the disorder, and ...

FDA Approves Zyprexa for Schizophrenia, Bipolar Disorder in Teens

December 5th, 2009
FDA Approves Zyprexa for Schizophrenia, Bipolar Disorder in TeensThe U.S. Food and Drug Administration (FDA) handed Eli Lilly & Co. approval to market its best-selling medication Zyprexa to teens with schizophrenia or bipolar ...

FDA Warns Pregnant Women Taking Depakote, Depakene

December 5th, 2009
FDA Warns Pregnant Women Taking Depakote, DepakeneThe U.S. Food and Drug Administration (FDA) last week notified health care professionals and patients about the increased risk of neural tube defects ...

Seroquel Gains FDA Approvals for Add-on Depression Treatment, Pediatric Schizophrenia

December 5th, 2009
Seroquel Gains FDA Approvals for Add-on Depression Treatment, Pediatric Schizophrenia The U.S. Food and Drug Administration (FDA) announced this past week that two types of Seroquel-brand (quetiapine fumarate) atypical antipsychotic medications have been approved ...

New Treatment for Schizophrenia and Bipolar Disorder

August 14th, 2009
New Treatment for Schizophrenia and Bipolar DisorderThe U.S. Food and Drug Administration (FDA) has approved Saphris tablets (asenapine) to treat adults with schizophrenia or bipolar disorder. "Mental illnesses like schizophrenia and bipolar disorder can be ...

Invega Antipsychotic Approved for Schizophrenia, Schizoaffective Disorder

August 6th, 2009
Invega Antipsychotic Approved for Schizophrenia, Schizoaffective DisorderLast week, the U.S. Food and Drug Administration (FDA) handed down two new approvals for Invega (paliperidone), an atypical antipsychotic medication, for the treatment of schizoaffective disorder, and ...

Once-Daily Trazodone Rejected by FDA

July 20th, 2009
Once-Daily Trazodone Rejected by FDAA once-daily form of trazodone, a second-generation antidepressant that has been available for the treatment of depression for decades, has been rejected by the U.S. Food ...